ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 650021 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 650021; 2) Community: the network communities that were significantly associated with the response to NSC 650021; 3) Molecule: the relationships between components within communities and NSC 650021; 4) MDR: the compounds that were significantly associated with the NSC 650021.

NSC Compound Enrichment Correlation
NSC 709358 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol 0.00070132188671658 0.22587036
NSC 683517 8H-Thieno[2,3-b]pyrrolizinium, 3-(4-bromophenyl)-4-methyl- 8-(1-pyrrolidinyl)-, iodide 0.000931492155975089 0.08968666
NSC 100880 Camptothecin 0.000931492155975116 0.20826353
NSC 139948 Null 0.00109467026514912 0.082977396
NSC 619321 Null 0.00109467026514912 0.079227104
NSC 696052 Null 0.00120351220784448 -0.13016621
NSC 669382 Null 0.00138752552318951 0.056736289
NSC 753907 Null 0.00138752552318951 0.014488454
NSC 656243 Benzo[1,2-b:5,4-b']dithiophene-2-carboxylic acid, 4,8-dioxo- 0.00172842815639259 -0.068682446
NSC 178248 Chlorozotocin 0.0018088833864761 0.22218453
Total:50  Current:2    [First] [Prev] [Next] [Last]